Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease (Q34654019)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease (English)

1 reference

Europe PubMed Central

3 August 2017

author name string

Kyle W Sloop

1

1 reference

Europe PubMed Central

3 August 2017

Aaron D Showalter

2

1 reference

Europe PubMed Central

3 August 2017

Amy L Cox

3

1 reference

Europe PubMed Central

3 August 2017

Julia X C Cao

4

1 reference

Europe PubMed Central

3 August 2017

Angela M Siesky

5

1 reference

Europe PubMed Central

3 August 2017

Hong Yan Zhang

6

1 reference

Europe PubMed Central

3 August 2017

Armando R Irizarry

7

1 reference

Europe PubMed Central

3 August 2017

Susan F Murray

8

1 reference

Europe PubMed Central

3 August 2017

Sheri L Booten

9

1 reference

Europe PubMed Central

3 August 2017

Eleftheria A Finger

10

1 reference

Europe PubMed Central

3 August 2017

Robert A McKay

11

1 reference

Europe PubMed Central

3 August 2017

Brett P Monia

12

1 reference

Europe PubMed Central

3 August 2017

Sanjay Bhanot

13

1 reference

Europe PubMed Central

3 August 2017

M Dodson Michael

14

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

3 May 2007

1 reference

Europe PubMed Central

3 August 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

3 August 2017

282

1 reference

Europe PubMed Central

3 August 2017

26

1 reference

Europe PubMed Central

3 August 2017

19113-19121

1 reference

Europe PubMed Central

3 August 2017

Regulation of glucose production by the liver

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

A glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Identification and characterization of a human cDNA and gene encoding a ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Transmembrane topology of human glucose 6-phosphate transporter

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

On the involvement of a glucose 6-phosphate transport system in the function of microsomal glucose 6-phosphatase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Recent advances in hepatic glucose 6-phosphatase regulation and function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Prospects for pharmacologic inhibition of hepatic glucose production

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Hepatic glucose production: therapeutic target in type 2 diabetes?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

The glucose-6-phosphatase system

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Correction of glycogen storage disease type 1a in a mouse model by gene therapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Calcium activates glucose-6-phosphatase in intact rat hepatic microsomes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Upregulation of hepatic glucose 6-phosphatase gene expression in rats treated with an inhibitor of glucose-6-phosphate translocase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Acute inhibition of hepatic glucose-6-phosphatase does not affect gluconeogenesis but directs gluconeogenic flux toward glycogen in fasted rats. A pharmacological study with the chlorogenic acid derivative S4048.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Nuclear magnetic resonance studies of hepatic glucose metabolism in humans.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Identifiers

10.1074/JBC.M610759200

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34654019&oldid=1977283050"